OUTLOOK THERAPEUTICS INC
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | +0.0% | -100.0% | – | -106.1% | – | – | -92.9% | – | |
| – | +151.4% | +0.0% | +1.7% | +0.4% | +0.0% | +1.0% | +1,411.3% | +108.4% | -96.8% | +404.0% | -88.6% | – | |
| – | – | – | – | – | – | – | – | -194.6% | – | – | – | – | |
| – | -8.4% | +198.3% | -17.1% | +11.8% | -22.9% | -54.4% | +61.9% | -16.2% | -39.2% | +23.8% | -27.8% | – | |
| – | -22.9% | -6.3% | +53.9% | +23.8% | +15.4% | -33.2% | +21.2% | +6.7% | -16.6% | +10.4% | -20.6% | – | |
| – | -17.1% | +83.5% | +3.3% | +16.8% | -5.6% | -42.6% | +35.7% | -3.0% | -24.9% | +14.4% | -22.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | -100.0% | -100.0% | – | – | – | +166.7% | +435.3% | – | – | – | – | |
| – | – | – | – | -87.2% | +205.3% | -366.7% | – | – | – | – | – | – | |
| – | -100.0% | – | -100.1% | – | – | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | -87.2% | +205.3% | -366.8% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.